GLP-1 Receptor Agonists Emerge as a New Frontier in Sleep Apnea Treatment Amidst Complex Insurance Landscape
The landscape of sleep apnea treatment is undergoing a significant evolution with the emergence of Glucagon-like Peptide-1 (GLP-1) receptor agonists, a class of medications initially developed for type 2 diabetes…
